KETANSERIN IN THE TREATMENT OF PROGRESSIVE SYSTEMIC-SCLEROSIS

[1] ALTOMARE GF, 1986, IN PRESS 3 ATT S INT

[2] CAMPBELL P M, 1975, Seminars in Arthritis and Rheumatism, V4, P351, DOI 10.1016/0049-0172(75)90017-7

[3] MICRO-VASCULAR PATHOGENESIS OF SCLERODERMA - HYPOTHESIS [J]. ANNALS OF INTERNAL MEDICINE, 1979, 91 (05) : 788 - 789

[4] HALPERN ALFRED, 1960, ANGIOLOGY, V11, P151, DOI 10.1177/000331976001100301

[5] HAUSTEIN UF, 1986, INT J DERMATOLO 0625, P286

[6] JANSSEN PAJ, 1982, ADV PHARMACOL THER, V4, P21

[7] INCREASED FACTOR-VIII-VONWILLEBRAND FACTOR ANTIGEN AND VONWILLEBRAND-FACTOR ACTIVITY IN SCLERODERMA AND IN RAYNAUD PHENOMENON [J]. ANNALS OF INTERNAL MEDICINE, 1981, 94 (04) : 482 - 484

[8] ENDOTHELIAL INJURY IN SCLERODERMA [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 149 (06) : 1326 - 1335

[9] PAGANO L, 1985, IN PRESS CLIN EXPT R

[10] TREATMENT OF RAYNAUDS-PHENOMENON WITH KETANSERIN, A SELECTIVE ANTAGONIST OF THE SEROTONIN2 (5-HT2) RECEPTOR [J]. ARTHRITIS AND RHEUMATISM, 1984, 27 (02): : 139 - 146

[1] ALTOMARE GF, 1986, IN PRESS 3 ATT S INT

[2] CAMPBELL P M, 1975, Seminars in Arthritis and Rheumatism, V4, P351, DOI 10.1016/0049-0172(75)90017-7

[3] MICRO-VASCULAR PATHOGENESIS OF SCLERODERMA - HYPOTHESIS [J]. ANNALS OF INTERNAL MEDICINE, 1979, 91 (05) : 788 - 789

[4] HALPERN ALFRED, 1960, ANGIOLOGY, V11, P151, DOI 10.1177/000331976001100301

[5] HAUSTEIN UF, 1986, INT J DERMATOLO 0625, P286

[6] JANSSEN PAJ, 1982, ADV PHARMACOL THER, V4, P21

[7] INCREASED FACTOR-VIII-VONWILLEBRAND FACTOR ANTIGEN AND VONWILLEBRAND-FACTOR ACTIVITY IN SCLERODERMA AND IN RAYNAUD PHENOMENON [J]. ANNALS OF INTERNAL MEDICINE, 1981, 94 (04) : 482 - 484

[8] ENDOTHELIAL INJURY IN SCLERODERMA [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 149 (06) : 1326 - 1335

[9] PAGANO L, 1985, IN PRESS CLIN EXPT R

[10] TREATMENT OF RAYNAUDS-PHENOMENON WITH KETANSERIN, A SELECTIVE ANTAGONIST OF THE SEROTONIN2 (5-HT2) RECEPTOR [J]. ARTHRITIS AND RHEUMATISM, 1984, 27 (02): : 139 - 146